Micromedic Technologies Ltd.

Micromedic Technologies Ltd. is a leading force in medical equipment manufacturing, specializing in the development and commercialization of innovative in vitro cancer diagnostic products and solutions. Micromedic Technologies is dedicated to advancing healthcare through state-of-the-art technologies for early cancer detection and personalized medicine.

Micromedic Technologies' CellDetect® is an innovative diagnostic platform targeting multiple cancer applications. It stands out as a histochemical stain that allows color discrimination alongside morphological examination for differentiation between normal and cancer cells. This versatile test is applicable for various sample types, including biopsy, urine, smear, and blood, and works with any specimen preparation platform, utilizing standard processes routinely used in pathology labs. The color-based feature of CellDetect® facilitates pathologists' examination, minimizes the need for expert analysis, and saves on lab costs. CellDetect® technology has the potential to enhance digital pathology by combining color and morphology.

Located in Kyriat Atidim, Tel Aviv, IL, Micromedic Technologies is committed to providing high-performance, cost-effective solutions for cancer diagnostics. CellDetect® Bladder cancer test offers a combination of performance and workflow that is unmatched. Clinical studies have demonstrated the high performance of CellDetect® for bladder cancer detection, with high sensitivity for early-stage tumors often missed by existing non-invasive tests. This technological breakthrough ensures early detection, which is instrumental in improving prognosis. We invite the manager of Micromedic Technologies Ltd. to create a customized and exclusive company showcase and product listing on our platform.